MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-13-0002537
Ariwell Pharma Private Limited
Ariwell Pharma Private Limited - jewelry & fashion accessories in Jabalpur, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹87,590
Latest filing
Net profit · FY 2025
₹438
Net margin 0.5%
EBITDA · FY 2025
₹438
EBITDA margin 0.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.2 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Ariwell Pharma Private Limited
Data last updated:
Ariwell Pharma Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 24 March 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33301MP2022PTC060044.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Meenakshi Singh and Kuldeep Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Aniruddh Singh H.No. 531 Apr – II Mandla Road Bilheri, Jabalpur, Madhya Pradesh, India – 482020.
As per the financials filed for FY 2025, the company reported a revenue of ₹87,590. For the same year it recorded a net profit of ₹438 (net margin 0.5%) and EBITDA of ₹438 (EBITDA margin 0.5%).
Ariwell Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-13-0002537).
Company details
CIN U33301MP2022PTC060044
Registration Number 060044
Incorporation Date 24 March 2022
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-13-0002537
Key People
Meenakshi Singh Director Kuldeep Singh Director Recognitions & Rankings of Ariwell Pharma
Contact details
Ariwell Pharma Private Limited's registered office is in Jabalpur, Madhya Pradesh.
- Registered AddressC/O Aniruddh Singh H.No. 531 Apr – II Mandla Road Bilheri, Jabalpur, Madhya Pradesh, India – 482020
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
Comprehensive company report
Ariwell Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Ariwell Pharma Private Limited
FY 2025 filings availableAriwell Pharma Private Limited reported revenue of ₹87,590 for FY 2025.
Revenue · FY 2025
₹87,590
Net profit · FY 2025
₹438 margin 0.5%
EBITDA · FY 2025
₹438 margin 0.5%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹438 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹438 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.5% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ariwell Pharma Private Limited, buy the company report.
Board of directors of Ariwell Pharma Private Limited
Ariwell Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meenakshi Singh | Director | 17 Aug 2022 | 4 Years 2 Months | Current |
| Kuldeep Singh | Director | 24 Mar 2022 | 4 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Ariwell Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ariwell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ariwell Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ariwell Pharma Private Limited has 5 board changes on record since 2022: 2 appointments and 3 cessations. The latest: Shiv Prakash ceased to be Director on 14 Feb 2024.
AGM
Ariwell Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Ariwell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Shiv Prakash ceased to be Director.
Appointed
Meenakshi Singh was appointed as Director.
Ceased
Shiv Narayan ceased to be Director.
Ceased
Sunit Singh ceased to be Director.
Appointed
Kuldeep Singh was appointed as Director.
Incorporation
24 Mar 2022
Ariwell Pharma Private Limited was registered on 24 Mar 2022 with Roc Gwalior & aged 4 years 7 months as per MCA records.
Frequently asked questions
Ariwell Pharma is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 24 March 2022 (4+ years old) and is registered under CIN U33301MP2022PTC060044.
Ariwell Pharma has 2 current directors:
- Meenakshi Singh - Director
- Kuldeep Singh - Director
The latest financial statements of Ariwell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ariwell Pharma is U33301MP2022PTC060044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ariwell Pharma was incorporated on 24 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
Shiv Prakash ceased to be Director on 14 Feb 2024. Meenakshi Singh was appointed as Director on 17 Aug 2022. Shiv Narayan ceased to be Director on 15 Aug 2022. Ariwell Pharma has 5 board changes on record in total.
Yes, Ariwell Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-13-0002537).
The registered office of Ariwell Pharma is at CO Aniruddh Singh H.No. 531 Apr – II Mandla Road Bilheri, Jabalpur, Madhya Pradesh, India – 482020.
Ariwell Pharma operates in the jewelry and fashion accessories industry, in the manufacturing segment.
Ariwell Pharma can be reached at its registered office: CO Aniruddh Singh H.No. 531 Apr – II Mandla Road Bilheri, Jabalpur, Madhya Pradesh, India – 482020.